[Morphologic and immunophenotypic analysis of angioimmunoblastic T-cell lymphoma]. 2009

Yuan-yuan Zheng, and Gang Chen, and Xiao-ge Zhou, and Shu-hong Zhang, and Yan-ning Zhang
Department of Pathology, Beijing Friendship Hospital, Capital University of Medical Sciences, Beijing 100050, China.

OBJECTIVE To study the morphologic and immunophenotypic features of angioimmunoblastic T-cell lymphoma (AITL), as well as the origin of the proliferative follicular dendritic cells (FDCs) in AITL. METHODS Immunohistochemical study for CD10, CXCL13, bcl-6 and CD21 was performed on 29 cases of AITL. Double immunostaining for bcl-6/CD3, CD10/CD21 and CD10/CD20 were also carried out. Cases of peripheral T-cell lymphoma, unspecified, extranodal NK/T-cell lymphoma, nasal-type, enteropathy-type T-cell lymphoma, anaplastic large cell lymphoma, subcutaneous panniculitis-like T-cell lymphoma and reactive lymphoid proliferation were selected as controls. RESULTS Amongst the 29 cases of AITL studied, 75.9% (22/29) showed aberrant expression of CD10, while all except one of the controlled cases were negative, 82.8% (24/29) of the AITL cases expressed CXCL13, while all cases of peripheral T-cell lymphoma, unspecified were negative. As for bcl-6 staining, although the highest percentage of bcl-6-positive cells was observed in AITL, the expression pattern was not useful in differentiating AITL from peripheral T-cell lymphoma, unspecified and lymphoid reaction. Besides, all cases of AITL demonstrated the characteristic proliferation of follicular dendritic cells. Two of the cases, which contained obvious germinal centers, had the follicular dendritic cell meshwork extending beyond the lymphoid follicles. CONCLUSIONS As compared with bcl-6, CD10 and CXCL13 are specific and sensitive markers in diagnosing AITL. Part of the proliferative FDCs in AITL may originate from the germinal centers.

UI MeSH Term Description Entries
D007119 Immunoblastic Lymphadenopathy A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly. Angioimmunoblastic Lymphadenopathy,Lymphadenopathy, Immunoblastic,Angioimmunoblastic Lymphadenopathies,Immunoblastic Lymphadenopathies,Lymphadenopathies, Angioimmunoblastic,Lymphadenopathies, Immunoblastic,Lymphadenopathy, Angioimmunoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015260 Neprilysin Enzyme that is a major constituent of kidney brush-border membranes and is also present to a lesser degree in the brain and other tissues. It preferentially catalyzes cleavage at the amino group of hydrophobic residues of the B-chain of insulin as well as opioid peptides and other biologically active peptides. The enzyme is inhibited primarily by EDTA, phosphoramidon, and thiorphan and is reactivated by zinc. Neprilysin is identical to common acute lymphoblastic leukemia antigen (CALLA Antigen), an important marker in the diagnosis of human acute lymphocytic leukemia. There is no relationship with CALLA PLANT. Antigens, CD10,Antigens, Leukemia, Common Acute Lymphoblastic,CALLA Antigen,CD10 Antigens,Common Acute Lymphoblastic Leukemia Antigens,Endopeptidase-24.11,Enkephalin Dipeptidyl Carboxypeptidase,Enkephalinase,Kidney-Brush-Border Neutral Proteinase,Membrane Metallo-Endopeptidase,Atriopeptidase,CD10 Antigen,Enkephalinase-24.11,Neutral Endopeptidase,Neutral Endopeptidase 24.11,Thermolysin-Like Metalloendopeptidase,YGG-Forming Enzyme,Antigen, CD10,Carboxypeptidase, Enkephalin Dipeptidyl,Dipeptidyl Carboxypeptidase, Enkephalin,Endopeptidase 24.11,Endopeptidase 24.11, Neutral,Endopeptidase, Neutral,Enkephalinase 24.11,Enzyme, YGG-Forming,Kidney Brush Border Neutral Proteinase,Membrane Metallo Endopeptidase,Metallo-Endopeptidase, Membrane,Metalloendopeptidase, Thermolysin-Like,Neutral Proteinase, Kidney-Brush-Border,Thermolysin Like Metalloendopeptidase,YGG Forming Enzyme
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte
D016411 Lymphoma, T-Cell, Peripheral A group of malignant lymphomas thought to derive from peripheral T-lymphocytes in lymph nodes and other nonlymphoid sites. They include a broad spectrum of lymphocyte morphology, but in all instances express T-cell markers admixed with epithelioid histiocytes, plasma cells, and eosinophils. Although markedly similar to large-cell immunoblastic lymphoma (LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC), this group's unique features warrant separate treatment. Peripheral T-Cell Lymphoma,T-Cell Lymphoma, Peripheral,Lymphoma, T Cell, Peripheral,Lymphoma, Peripheral T-Cell,Lymphomas, Peripheral T-Cell,Peripheral T Cell Lymphoma,Peripheral T-Cell Lymphomas,T Cell Lymphoma, Peripheral,T-Cell Lymphomas, Peripheral

Related Publications

Yuan-yuan Zheng, and Gang Chen, and Xiao-ge Zhou, and Shu-hong Zhang, and Yan-ning Zhang
January 2010, Indian journal of pathology & microbiology,
Yuan-yuan Zheng, and Gang Chen, and Xiao-ge Zhou, and Shu-hong Zhang, and Yan-ning Zhang
January 2010, Human pathology,
Yuan-yuan Zheng, and Gang Chen, and Xiao-ge Zhou, and Shu-hong Zhang, and Yan-ning Zhang
July 2006, American journal of clinical pathology,
Yuan-yuan Zheng, and Gang Chen, and Xiao-ge Zhou, and Shu-hong Zhang, and Yan-ning Zhang
December 2021, Diagnostic cytopathology,
Yuan-yuan Zheng, and Gang Chen, and Xiao-ge Zhou, and Shu-hong Zhang, and Yan-ning Zhang
September 2019, Journal of cutaneous pathology,
Yuan-yuan Zheng, and Gang Chen, and Xiao-ge Zhou, and Shu-hong Zhang, and Yan-ning Zhang
April 2007, American journal of clinical pathology,
Yuan-yuan Zheng, and Gang Chen, and Xiao-ge Zhou, and Shu-hong Zhang, and Yan-ning Zhang
May 2024, Annals of hematology,
Yuan-yuan Zheng, and Gang Chen, and Xiao-ge Zhou, and Shu-hong Zhang, and Yan-ning Zhang
April 1996, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Yuan-yuan Zheng, and Gang Chen, and Xiao-ge Zhou, and Shu-hong Zhang, and Yan-ning Zhang
December 2016, Leukemia & lymphoma,
Yuan-yuan Zheng, and Gang Chen, and Xiao-ge Zhou, and Shu-hong Zhang, and Yan-ning Zhang
May 1990, Medicina clinica,
Copied contents to your clipboard!